-
BioLamina appoints Brian Hawkins, PhD as new Chief Technology Officer (CTO).
Stockholm, March 3, 2025 BioLamina appoints Brian Hawkins, PhD, as new Chief Technology Officer (CTO). BioLamina AB, appoints Brian Hawkins […]
-
Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx
Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx We are proud to have been chosen by PluriStyx […]
-
Webinar: Treating Blindness with Stem Cell Therapies
How close are we to one-shot stem cell therapies for eye disease? What are the critical factors for successful translation to the clinic? Join us for the panel discussion!
-
Join us for our webinar with Prof. Dr. Kasri – neurodevelopmental disorder research with MEA and laminin
Join us for our webinar “Neurons are talking…are you listening?” with Prof. Dr. Kasri from Radboud UMC — Bridging the […]
-
BioLamina AB appoints Klaus Langhoff-Roos as new CEO.
Stockholm August 15, 2024 BioLamina appoints Klaus Langhoff-Roos as new CEO. BioLamina AB, a leading maker of reagents for stem […]
-
Meet us at ISSCR 2024, July 10–13
Meet us at ISSCR 2024, July 10–13 We look forward to meeting you at ISSCR 2024, July 10–13 in Hamburg, […]
-
Meet us at ISCT 2024, May 29–June 1
Meet us at ISCT 2024, May 29–June 1 We are looking forward to meeting you at ISCT 2024, May 29–June […]
-
Meet us at our next events!
Meet us at our next events Meet us to discuss how we can help you revolutionize cell culture. We will […]
-
Meet us at Mercia Stem Cell Alliance Meeting, December 4
Meet us at Mercia Stem Cell Alliance Meeting, December 4 We are looking forward to meeting you at Mercia Stem […]
-
Meet us at ISSCR Vienna, December 4–6
Meet us at ISSCR Vienna International Symposium, December 4–6 We are looking forward to meeting you at International Society for Stem […]